CA2392351A1 - Novel transcription factor and dna thereof - Google Patents

Novel transcription factor and dna thereof Download PDF

Info

Publication number
CA2392351A1
CA2392351A1 CA002392351A CA2392351A CA2392351A1 CA 2392351 A1 CA2392351 A1 CA 2392351A1 CA 002392351 A CA002392351 A CA 002392351A CA 2392351 A CA2392351 A CA 2392351A CA 2392351 A1 CA2392351 A1 CA 2392351A1
Authority
CA
Canada
Prior art keywords
dna
polypeptide
present
seq
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002392351A
Other languages
English (en)
French (fr)
Inventor
Koji Yoshimura
Yuichi Hikichi
Kenichi Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2392351A1 publication Critical patent/CA2392351A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002392351A 1999-11-26 2000-11-24 Novel transcription factor and dna thereof Abandoned CA2392351A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/336475 1999-11-26
JP33647599 1999-11-26
PCT/JP2000/008257 WO2001038392A1 (fr) 1999-11-26 2000-11-24 Nouveau facteur de transcription et son adn

Publications (1)

Publication Number Publication Date
CA2392351A1 true CA2392351A1 (en) 2001-05-31

Family

ID=18299528

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002392351A Abandoned CA2392351A1 (en) 1999-11-26 2000-11-24 Novel transcription factor and dna thereof

Country Status (8)

Country Link
US (1) US7241860B1 (enExample)
EP (1) EP1233023B1 (enExample)
JP (1) JP2001211890A (enExample)
AT (1) ATE286911T1 (enExample)
AU (1) AU1549701A (enExample)
CA (1) CA2392351A1 (enExample)
DE (1) DE60017453T2 (enExample)
WO (1) WO2001038392A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05178896A (ja) 1990-08-23 1993-07-20 Mitsubishi Kasei Corp 新規なタンパク質、それをコードする遺伝子及びその産生方法
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
US5851775A (en) * 1997-03-20 1998-12-22 Johns Hopkins University β-catenin, Tcf-4, and APC interact to prevent cancer

Also Published As

Publication number Publication date
ATE286911T1 (de) 2005-01-15
US7241860B1 (en) 2007-07-10
EP1233023A1 (en) 2002-08-21
DE60017453T2 (de) 2005-12-22
JP2001211890A (ja) 2001-08-07
WO2001038392A1 (fr) 2001-05-31
EP1233023B1 (en) 2005-01-12
DE60017453D1 (de) 2005-02-17
AU1549701A (en) 2001-06-04
EP1233023A4 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
US7556926B2 (en) Methods for screening insulin-sensitizing agents
US7247705B2 (en) Proteins having glucose transporter activity
US6844179B1 (en) Protein and DNA thereof
EP1191099B1 (en) Novel polypeptide and dna thereof
US20040234990A1 (en) Method of screening alzheimer's disease-associated gene
US7064106B2 (en) Gene and use thereof
EP1233023B1 (en) Transcription factor and dna thereof
US20070065819A1 (en) Novel fprl1 ligands and use thereof
EP1447411A1 (en) Novel protein, its dna and use thereof
EP1375663A1 (en) Novel protein, dna thereof and use of the same
US20090227501A1 (en) Agents for preventing and/or treating upper digestive tract disorders
EP1428877A1 (en) Novel protein and dna thereof
US7355001B2 (en) Organic anion transport protein TCH229
US7176010B2 (en) Isolated human protein having esterase activity and DNA encoding the same
JP4300008B2 (ja) 新規タンパク質およびそのｄｎａ
US20060111556A1 (en) Preventives/remedies for neurodegenerative diseases
US20050208494A1 (en) Novel proteins and dnas thereof
US20060051343A1 (en) Preventives remedies for bone and joint diseases
US20030186304A1 (en) Novel disease-associated gene and use thereof
JP2003144177A (ja) 新規タンパク質、そのｄｎａおよびその用途

Legal Events

Date Code Title Description
FZDE Discontinued